Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab

Kathrin Hanfstingl; Agnes Pekar-Lukacs; Reinhard Motz; Emmanuella Guenova; Wolfram Hoetzenecker

doi:10.1159/000488902

Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab

Case Rep Dermatol. 2018 May 2;10(2):97-100. doi: 10.1159/000488902. eCollection 2018 May-Aug.

Authors

Kathrin Hanfstingl¹, Agnes Pekar-Lukacs², Reinhard Motz³, Emmanuella Guenova⁴, Wolfram Hoetzenecker¹

Affiliations

¹ Department of Dermatology, Kepler University Hospital Linz, Linz, Austria.
² Department of Oncology and Pathology, University of Lund, Lund, Sweden.
³ Department of Pathology, Kepler University Hospital Linz, Linz, Austria.
⁴ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

Abstract

Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause and often confounded with psoriasis. It is characterised by hyperkeratotic follicular papules, scaly erythematous plaques, palmoplantar keratoderma, and a progression to generalised erythroderma. Here, we report the case of a 68-year-old man with pityriasis rubra pilaris, who was successfully treated with ixekizumab, an interleukin-17A inhibitor.

Keywords: Ixekizumab; Pityriasis rubra pilaris; Successful treatment.

Publication types

Case Reports